Format
Sort by

Send to

Choose Destination

Links from PubChem BioAssay

Items: 11

1.

Lipoprotein-associated phospholipase A(2) and atherosclerosis.

Wilensky RL, Macphee CH.

Curr Opin Lipidol. 2009 Oct;20(5):415-20. doi: 10.1097/MOL.0b013e3283307c16. Review.

PMID:
19667981
2.
3.

Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.

Anderson JL.

Am J Cardiol. 2008 Jun 16;101(12A):23F-33F. doi: 10.1016/j.amjcard.2008.04.015. Review.

PMID:
18549868
4.

Plasma PAF-acetylhydrolase: an unfulfilled promise?

Karabina SA, Ninio E.

Biochim Biophys Acta. 2006 Nov;1761(11):1351-8. Review.

PMID:
16807087
5.

Oxidized phospholipids as triggers of inflammation in atherosclerosis.

Leitinger N.

Mol Nutr Food Res. 2005 Nov;49(11):1063-71. Review.

PMID:
16270279
7.

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2.

Blackie JA, Bloomer JC, Brown MJ, Cheng HY, Hammond B, Hickey DM, Ife RJ, Leach CA, Lewis VA, Macphee CH, Milliner KJ, Moores KE, Pinto IL, Smith SA, Stansfield IG, Stanway SJ, Taylor MA, Theobald CJ.

Bioorg Med Chem Lett. 2003 Mar 24;13(6):1067-70.

PMID:
12643913
8.

Plasma platelet activating factor-acetylhydrolase (PAF-AH).

Karasawa K, Harada A, Satoh N, Inoue K, Setaka M.

Prog Lipid Res. 2003 Mar;42(2):93-114. Review.

PMID:
12547653
9.

The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis.

Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM.

Crit Care Med. 2002 May;30(5 Suppl):S294-301. Review.

PMID:
12004251
10.
11.

Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF).

Farr RS, Cox CP, Wardlow ML, Jorgensen R.

Clin Immunol Immunopathol. 1980 Mar;15(3):318-330. No abstract available.

PMID:
7371225
Items per page

Supplemental Content

Support Center